Literature DB >> 10654643

Mycobacterium tuberculosis and human immunodeficiency virus co-infection in intravenous drug users on admission to prison.

V Martín1, J A Caylà, A Bolea, J Castilla.   

Abstract

BACKGROUND: Intravenous drug users (IDUs) and prisoners are groups of great interest in human immunodeficiency virus (HIV) infection and tuberculosis (TB) epidemiology. AIM: To determine predictors and temporal trends of the co-infection of Mycobacterium tuberculosis and HIV in IDUs on admission to prison. PATIENTS AND METHODS: Between 1 January 1991 and 31 December 1997, 796 IDUs or former IDUs were studied. Socio-demographic and penitentiary variables were evaluated. HIV-positive patients with > or =5 mm induration on tuberculin test were deemed co-infected. Analysis of factors associated with co-infection was based on a logistic regression model.
RESULTS: Of the incoming prisoners, 44.0% were infected by M. tuberculosis, 43.8% by HIV and 20.1% were co-infected. Co-infection predictors were: 1) total prison time served previously (none, OR 1; <2 years, OR 2.44, 95% CI 1.28-4.64; > or =2 years, OR 4.94, 95% CI 2.56-9.55); 2) age (16-25 years, OR 1; 25-29 years, OR 3.14, 95% CI 1.71-5.75; >29 years, OR 3.67, 95% CI 1.96-6.86); 3) tattoos (OR 1.56, 95% CI 0.98-2.49), 4) syringe sharing (OR 2.43, 95% CI 1.57-3.77) and 5) ex-IDU status (OR 1.87, 95% CI 1.23-2.82). No statistically significant variation in the annual co-infection tendency was observed (OR 1.10, 95% CI 0.98-1.22).
CONCLUSIONS: The high prevalence of co-infection that was detected was associated with risk factors that could be amended by public health intervention.

Entities:  

Mesh:

Year:  2000        PMID: 10654643

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  The growing impact of HIV infection on the epidemiology of tuberculosis in England and Wales: 1999 2003.

Authors:  Aliko B Ahmed; Ibrahim Abubakar; Valerie Delpech; Marc Lipman; Delia Boccia; Josh Forde; Delphine Antoine; John M Watson
Journal:  Thorax       Date:  2007-02-20       Impact factor: 9.139

2.  The burden and characteristics of tuberculosis/human immunodeficiency virus (TB/HIV) in South Korea: a study from a population database and a survey.

Authors:  Chang-Hoon Lee; Ji-Young Hwang; Dae-Kyu Oh; Mee-Kyung Kee; Eunjung Oh; Jung-Wook An; Jinhyun Kim; Heonsook Do; Hee-Jin Kim; Sung Soon Kim; Hwahyun Kim; Jeong-Gu Nam
Journal:  BMC Infect Dis       Date:  2010-03-12       Impact factor: 3.090

Review 3.  Tuberculosis and illicit drug use: review and update.

Authors:  Robert G Deiss; Timothy C Rodwell; Richard S Garfein
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

4.  High prevalence of latent tuberculosis infection among injection drug users in Tijuana, Mexico.

Authors:  R S Garfein; R Lozada; L Liu; R Laniado-Laborin; T C Rodwell; R Deiss; J Alvelais; A Catanzaro; P G Chiles; S A Strathdee
Journal:  Int J Tuberc Lung Dis       Date:  2009-05       Impact factor: 2.373

5.  Mycobacterium tuberculosis infection among persons who inject drugs in San Diego, California.

Authors:  R F Armenta; K M Collins; S A Strathdee; M A Bulterys; F Munoz; J Cuevas-Mota; P Chiles; R S Garfein
Journal:  Int J Tuberc Lung Dis       Date:  2017-04-01       Impact factor: 2.373

6.  Prevalence of latent tuberculosis infection and associated risk factors in prison in East Wollega Zone of western Ethiopia.

Authors:  Basha Chekesa; Balako Gumi; Mahlet Chanyalew; Aboma Zewude; Gobena Ameni
Journal:  PLoS One       Date:  2020-05-19       Impact factor: 3.240

7.  Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners.

Authors:  Giuseppe La Torre; Luca Miele; Giacomina Chiaradia; Alice Mannocci; Manuela Reali; Giovanni Gasbarrini; Elisabetta De Vito; Antonio Grieco; Walter Ricciardi
Journal:  BMC Infect Dis       Date:  2007-08-30       Impact factor: 3.090

8.  Smear positive pulmonary tuberculosis and HIV co-infection in prison settings of North Gondar Zone, Northwest Ethiopia.

Authors:  Teklay Gebrecherkos; Baye Gelaw; Belay Tessema
Journal:  BMC Public Health       Date:  2016-10-18       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.